We are currently witnessing a dramatic change in lifestyle and food choices that is accompanied with an increase in the rate of morbidity and mortality from cardiovascular diseases (CVD). Although studies have reported an association of CVD with hyperhomocysteinemia-mediated oxidative stress, the biochemical basis is not known. This case-control study was aimed to evaluate the nutritional and biochemical status of B-vitamins in relation to hyperhomocysteinemia and oxidative stress in newly diagnosed cardiac patients. The retrospective dietary intake of the study subjects (cases and controls) was estimated using a semi-quantitative food frequency questionnaire, and fasting blood samples were drawn to assess their serum levels of B-vitamins (folate, vitamins B 6 and B 12 ), homocysteine (HCY), and oxidative stress indices such as glutathione (GSH), total antioxidant capacity (TAC), malondialdehyde (MDA), and nitrites and nitrates (NN). It was observed that the cases had a lower dietary intake of Bvitamins as compared to their matched control subjects as well as to the corresponding recommended dietary allowances. Biochemical analysis of cases, as compared to controls, indicated depletion of GSH, impairment of TAC, and an elevation in the serum levels of HCY, MDA, and NN. These results suggest that lower status (dietary intake and serum levels) of B-vitamins is involved in the etiology of hyperhomocysteinemia and oxidative stress, the typical risk factors for CVD.
Introduction
Cardiovascular diseases (CVDs) are one of the non-communicable diseases (NCDs), associated with westernization of lifestyle and food choices, and can be prevented through healthy diet, and regular physical activity. 1 CVDs are a major global health problem, and it has been postulated that by the year 2020, the CVDs will surpass other NCDs and infectious diseases as the world's leading cause of mortality and morbidity. 2 The CVDs risk factors include both modifiable and nonmodifiable risk factors; B vitamins (folate, vitamin B 6 and vitamin B 12 ) are one of the modifiable dietary risk factors for CVDs, based on their significant metabolic effects on homocysteine (HCY) metabolism as illustrated in Figure 1 . [3] [4] [5] [6] It has been reported that nutritional deficiencies of folate, vitamins B 6 , and B 12 inhibit the enzymes that mediate the HCY-dependent transmethylation and transsulfuration pathways resulting in hyperhomocysteinemia and are associated with pathophysiological consequences mainly the induction of oxidative stress as evident by the intracellular glutathione (GSH) depletion. [7] [8] [9] [10] [11] Hyperhomocysteinemia and oxidative stress, as reported by many studies, are involved in the pathogenesis of CVDs. [12] [13] [14] Previous studies conducted in relation to the etiological factors of CVD incidence mainly focused on the non-modifiable risk factors, classical risk factors, including hypertension, lipidemia, and hypercholesterolemia. However, no studies attempted to identify the biochemical and nutritional basis of B-vitamins as modifiable risk factors for CVDs. Therefore, in the present study we evaluated the biochemical and nutritional status of folate, vitamins B 6 , and vitamin B 12 in relation to HCY, and oxidative stress in newly diagnosed cardiac patients.
Materials and methods

Study subjects
A case-control study design was used to conduct this study at Royal Hospital Muscat, a tertiary hospital and the main referral hospital for cardiac cases, in the Sultanate of Oman. The cardiac patients included in this study were recruited from the recently diagnosed Omani nationals suffering with acute CVDs and admitted to cardiology department. The criteria of CVDs diagnosis were based on the symptoms, enzymatic changes, and electrocardiogram changes. The inclusion criteria was newly diagnosis with CVDs (angina and myocardial infarction), with no previous diagnosis of CVD, atherosclerosis or any other types of hyperlipidemia. The exclusion criteria were the presence of metabolic disorders, cancer, type-2 diabetes, hypothyroidism, or chronic renal diseases. According to the inclusion and exclusion criteria, 25 cases were enrolled during the period of this study, and controls (n ¼ 25), healthy subjects, were recruited on voluntary basis and matched for age and gender with the cases. None of the study participants were consuming lipid-lowering drugs. The study was approved by the Medical Research Ethics Committee of Ministry of Health, Oman, MESRC#76.
Study questionnaire
In-person interviews were scheduled for all the study participants. The enrolled cardiac patients and controls were asked to complete the study questionnaire that included questions related to: (1) Socio-demographic data: smoking, alcohol drinking, medical family history, intake of vitamins and nutritional supplements, monthly income, and physical activity; (2) Anthropometric measurements: weight and height to calculate body mass index (BMI kg/m 2 ) for all study participants; (3) Dietary intake assessment: the retrospective dietary intake of the study participants was estimated using a semi-quantitative food frequency questionnaire (FFQ). All study participants were asked to report the frequency of food intake, how often, and what portion size for each food item they consumed during a period of six months prior to the CVDs attack for cases, and prior to the study questionnaire interview for controls. The eight different food groups included in the FFQ were: breads/cereals, vegetables, fruits, meat/meat substitutes, milk/dairy products, deserts, beverages, and sandwiches. The collected dietary intake data were analyzed using the Food Processor Software Version 10.2 (ESHA Research, Salem, OR) to calculate the means of daily intake of macronutrients (protein, carbohydrate, and fat), folate, vitamin B 6 , and vitamin B 12 as estimated from the frequency of consumption, reported portion size, and nutrients content for all foods reported by each study participant. The FFQ was developed in collaboration with the Nutrition Department, High Institute of Public health, Alexandria University, Egypt.
Biochemical analysis
Fasting blood samples were drawn after overnight fasting into two types of tubes (plain top and purple top tubes). The purple top tube was used for red blood cells folate measurement, 15 and the plain top tube was used for serum separation by centrifugation and storage at À80 C for subsequent Figure 1 Simplified schematic of the homocysteine-dependent transmethylation and transsulfuration pathways. Homocysteine is methylated into methionine by methionine synthase enzyme, which utilizes vitamin B 12 as a cofactor and acquires a methyl group from folate which is subsequently converted to tetrahydrofolate. Methionine is further converted to S-adenosylmethionine, through the activity of methionine adenosyl transferase enzyme, which is the major methyl donor for all methyltransferases that add methyl groups to various acceptor molecules such as DNA, RNA, phospholipids, and proteins. S-adenosylmethionine is then converted to S-adenosylhomocysteine which is reversibly converted to homocysteine in a reaction catalyzed by hydrolase enzyme. Based on the methionine synthase enzyme activity and the availability of folate and vitamin B 12 , homocysteine is remethylated back to methionine, or transulfurated into glutathione biosynthesis pathway that requires vitamin B 6 analyses. Folate, vitamins B 6 , and B 12 were measured in the sera of the study participants using an automated randomaccess immunoassay system (Siemens Medical Solutions Diagnostics, ADVIA Centaur Chemistry Analyser, Bohemia, NY). The serum HCY levels were determined by the Immulite 2000 Homocysteine Analyser. 16 Serum oxidative stress markers were measured according to the manufactures' instructions (BioVision, Inc., CA) in each kit: GSH by assay kit K251, the total antioxidant capacity (TAC) by assay kit K274, malondialdehyde (MDA) by assay kit K739, and nitrites and nitrates (NN) by assay kit K262.
Statistical analysis
The collected data were reviewed for completeness and accuracy. Data were presented as mean AE standard deviation (SD), and analyzed by the appropriate statistical procedures using ''The Statistical Package GraphPad Prism version 5''. Chi-squared ( 2 ) test was used to analyze the categorical variables. The unpaired Student's t-test and simple correlation coefficients (r) were quantified for assessing the correlations between HCY and different variables. P < 0.05 is considered statistically significant.
Results
General characteristics
Twenty-five cases, cardiac patients (12 males and 13 females), were recruited on voluntary basis in accordance to the inclusion and exclusion criteria for this study. For each case, one control (healthy subject) was matched for age and gender. It was observed that 64% of the enrolled cases were suffering from myocardial infarction, 24% from stable angina, and 12% from unstable angina. There was no significant differences between mean age (years) for the cases and controls, 54.72 AE 10.3 and 53.81 AE 6.8, respectively, t ¼ 0.368, P > 0.05. The percentage distribution of the cases by their smoking status was majority of the cases (72%) were non-smokers and only 28% were smokers, meanwhile none of the enrolled controls were smokers.
Physical activity and anthropometric measurements
The cases were distributed by their physical activity level into two categories: 76% were in the category of light activity whereas 24% had moderate activity. The same pattern was observed for controls, where 68% had light activity and 32% had moderate activity. None of the enrolled cases or controls was performing any routine physical exercise. The difference between the cases and controls with regard to their physical activities was non-significant, 2 ¼ 0.511, P ¼ 0.774. The mean body weight (kg) for the enrolled cases and controls was 68.8 AE 14.8 and 69.2 AE 13.1, respectively. The mean height (cm) was 156.2 AE 9.2 and 155.9 AE 8.4, respectively. The average BMI (kg/m 2 ) for cases and controls was 28.3 AE 4.8 and 28.8 AE 1.55, respectively, with no significant difference, t ¼ 0.496, P > 0.05, showing prevalence of overweight among cases and controls.
Daily macronutrients intake
The daily macronutrients intake of the cases and controls is presented in Table 1 . It was observed that the cases consumed significantly higher amounts of protein as compared to controls (t ¼ 4.22, P < 0.05), however the cases consumed significantly lower daily intake of fat, carbohydrate, and total energy as compared to controls (t ¼ 6.81, t ¼ 3.49 and t ¼ 4.04, P < 0.05, respectively).
Daily intake and serum levels of B-vitamins
The data on dietary intake and serum levels of folate, vitamin B 6 , and vitamin B 12 are summarized in Table 2 . It was noted that the cases had lower levels of dietary intake of these micronutrients as compared to both their matched controls as well as with respect to the dietary reference intakes. The same pattern was observed for these micronutrients in the serum levels of cases as compared to controls and serum reference values. The differences were statistically significant, P < 0.05. Values are expressed as mean AE SD. The asterisk denotes that the data in cases are significantly higher than controls, whereas the hash mark denotes that data are significantly lower than controls group, P < 0.05. Figure 2 shows the mean red blood cells folate content of cases and controls. The cases had significantly lower folate levels as compared to controls. These results suggest that cases had a chronic low dietary intake of folate. The red blood cells' folate content of cases was also lower than the corresponding folate reference value, 450-1400 ng/mL.
Red blood cells' folate
Hyperhomocysteinemia
Serum HCY levels of the cases were significantly higher (t ¼ 18.22, P < 0.05) than controls and higher than the normal HCY serum reference value, 10-15 mmol/L; indicating the existence of hyperhomocysteinemia among cases (Figure 3 ). The serum HCY was negatively correlated with serum folic acid, vitamins B 6 , and B 12 levels (r ¼ À0.465, r ¼ À0.321, r ¼ À0.398, P < 0.05, respectively). However, there was no correlation between the serum levels of HCY, BMI, or age. The correlation between serum HCY and red blood cells folate level was weak and non-significant (r ¼ À0.213, P > 0.05).
Oxidative stress
Significantly lower levels of serum GSH and TAC (8.21 AE 0.89 mmol/L and 28.92 AE 1.1 mmol/L, respectively) were observed among cases as compared to controls (28.92 AE 1.1 mmol/L and 122.3 AE 12.89 mmol/L, respectively), P < 0.05. The oxidative stress indices (MDA and NN) were significantly higher in cases as compared to controls, P < 0.05, Table 3 .
Discussion
A steady increase in the prevalence of CVDs has been linked to adopting a sedentary lifestyle, with the classical risk factors such as hypertension, smoking, hyperlipidemia, and type-2 diabetes. There was an association between the elevated serum HCY level and an increased risk of CVDs incidence. 13 The serum HCY concentration of >10 mmol/L can increase the risk of CVD in a linear dose-response relationship with no specific threshold levels, and it was suggested that a reduction of elevated HCY concentrations (<10 mmol/L) may theoretically prevent up to 25% risk of cardiovascular events. 17 High fasting serum HCY and low folate and vitamin B 12 have also been suggested as clinical biomarkers for the early diagnosis of different human diseases among various population groups. 18 Folate deficiency is considered as the most common cause of hyperhomocysteinemia, and there is an increasing demand for the diagnosis and treatment of elevated serum HCY level in high-risk individuals in general and patients with manifest vascular disease in particular. 19 Our study has addressed the preventable risk factors associated with CVDs, using biochemical and nutritional approaches. Inadequate dietary intake of folate, vitamins B 6 , and B 12 has been associated with hyperhomocysteinemia based on their biochemical role as cofactors for enzymes mediated trans-methylation and transsulfuration pathways of HCY. The results of the present study highlighted this relationship among newly diagnosed cardiac patients, where it was observed that the dietary intake of folate in cases was lower than the dietary reference intakes for folate among adults and this was a determinate factor for lower levels of serum folate and red blood cells folate contents, short-term and long-term indicators of folate nutritional status, respectively. The same observation applied for vitamin B 6 and vitamin B 12 .
Folate and vitamin B 12 are required for methylation of HCY to methionine, and it was suggested that reduced plasma levels of folate, vitamin B 6 , and vitamin B 12 are associated with elevated level of HCY, hyperhomocysteinemia. Furthermore, our study revealed that hyperhomocysteinemia causes depletion of GSH and impairment of TAC indicating a cellular oxidative stress condition, as evident by an increase in reactive oxygen species products, MDA and NN. These results are in agreement with data from previous studies that an imbalance between ROS production and antioxidant levels exists in patients with CVDs and hyperhomocysteinemia. 20, 21 It was recommended that food grain fortification with folate and cobalamin supplement as an effective approach for CVD prevention. 22 Vitamin B 6 is required as a cofactor for transsulfuration of HCY into its metabolites, cystathionine, cysteine, and GSH. Lower levels of vitamin B 6 induce the accumulation of HCY and subsequently the development of hyperhomocysteinemia. 22 The mean red blood cells' folate content in cases was significantly lower in cases as compared to controls. The measurement of folate in red blood cells is preferred since it reflects long-term folate status in the body as compared to plasma or serum folate that may be influenced by recent dietary intakes. 23 The correlation between serum HCY and red blood cells folate content was however weak and non-significant. These findings are consistent with the body of evidence in research that elevated HCY level is an etiological factor for CVD.
Adopting a healthy lifestyle pattern reduces CVD risk factors such as dyslipidemia and obesity. 17 The CVD patients enrolled in this study had a sedentary lifestyle as demonstrated by their low level of routine occupational physical activity (76%) as well as lack of physical activity in their leisure time (68%). The incidence of CVD is common among those who adopt a sedentary lifestyle and is considered to be a global health problem among different population groups and nations.
Lack of physical activity predisposes obesity, insulin resistance, high level of low density lipoprotein, and triglycerides, which are considered as the common risk factors for CVD. 24, 25 Regular physical activity is considered as an effective intervention for reducing the risk of CVD. 24 The American Heart Association has listed obesity as a major risk factor for CVD, and our data revealed that the majority of CVD cases were overweight, this is quiet alarming since the rate of mortality and sudden death has been reported to be higher among subjects with BMI >27 kg/m 2 . 24 The cases consumed significantly higher amounts of protein in particular from animal sources as compared to controls. The intake of animal protein was also higher than the daily dietary recommended allowance (60 g/day). The high protein intake has been associated with CVDs risk, in particular if it is from animal sources. The cases had a lower intake of total fat, mainly from saturated fats, which is contraindicating the notion that there is a causal relationship between saturated fat consumption and the risk of developing CVD. The daily intake of carbohydrate as well as total energy in cases was also lower than the controls. Previous studies reported a decrease in usual food intake of people identified at high risk of CVD prior to diagnosis, as evident by low intake of fruits, vegetables, bread, grains, and fat. 25, 26 Therefore nutrition knowledge of healthy-eating recommendations in relation to CVD risk is recommended to initiate and maintain lifestyle changes among high risk groups. 27 High dietary fat intake is generally involved in the etiology of high rate of adiposity and fat storage for prolonged periods leading to obesity and is considered to be atherogenic in terms of its effect on serum lipids profile and effect on thrombosis and endothelial functions. 28 It has been suggested that adults consuming energy-dense foods have been shown to have higher risk of CVD. 29 HCY is a cytotoxic metabolite that promotes oxidation of low density lipoproteins, and induces inflammation in vascular smooth muscles and impairs the endothelial function with a potential of pathogenesis of atherosclerosis, a major risk factor for CVD. 30, 31 In conclusion, our findings suggest that hyperhomocysteinemia and oxidative stress were common among the enrolled newly diagnosed cardiac patients; they also had a low dietary intake of folate, vitamins B 6 , and B 12 as compared to controls. The measured serum HCY of cases was negatively correlated with their serum folate and vitamins B 6 and B 12 levels. No correlation was observed between serum HCY, BMI, and age. The mean red blood cells folate content in cases was significantly lower in cases as compared to controls. The correlation between serum HCY and red blood cells folate content was weak and non-significant. Our study highlights the importance of adopting early nutritional and healthy community-based intervention programs for the primary prevention of CVDs among high risk groups in particular with the adolescent population.
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